Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
- 29 February 2020
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 26 (8), 1024-1033
- https://doi.org/10.1016/j.cmi.2020.02.017
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrataAntimicrobial Agents and Chemotherapy, 2012
- High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to ItraconazoleAntimicrobial Agents and Chemotherapy, 2012
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008Antimicrobial Agents and Chemotherapy, 2011
- Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)Journal of Clinical Microbiology, 2011
- Breakthrough Invasive Candidiasis in Patients on MicafunginJournal of Clinical Microbiology, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Association of Fluconazole Pharmacodynamics with Mortality in Patients with CandidemiaAntimicrobial Agents and Chemotherapy, 2008
- Correlation of the MIC and Dose/MIC Ratio of Fluconazole to the Therapeutic Response of Patients with Mucosal Candidiasis and CandidemiaAntimicrobial Agents and Chemotherapy, 2007
- Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with CandidemiaAntimicrobial Agents and Chemotherapy, 2007
- Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with CryptococcosisAntimicrobial Agents and Chemotherapy, 2006